Lexington, MA, United States of America

Julius Juarez

This inventor holds 1 USPTO granted patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Julius Juarez. Retrieved from https://idiyas.com/inventor/julius-juarez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Julius Juarez

Introduction

Julius Juarez is an accomplished inventor based in Lexington, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative antibodies. His work is recognized for its potential impact on medical treatments.

Latest Patents

Julius holds a patent for "Anti-Vedolizumab Antibodies and Uses Thereof." This patent represents a crucial advancement in therapeutic options for patients requiring targeted treatments. His innovative approach has the potential to improve patient outcomes significantly.

Career Highlights

Julius is currently employed at Takeda Pharmaceutical Company Limited, where he continues to push the boundaries of pharmaceutical research. His dedication to innovation has positioned him as a key player in the development of new medical therapies.

Collaborations

Julius collaborates with Brandi Lynn Bailey, leveraging their combined expertise to drive forward-thinking research initiatives. Their partnership exemplifies the importance of teamwork in achieving groundbreaking results in the pharmaceutical industry.

Conclusion

Julius Juarez's contributions to the field of pharmaceuticals through his patent and collaborative efforts highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…